Investigating how IL-17 affects bacterial infections during flu

Pathogenic role of IL-17 response in Streptococcus pneumoniae nasopharyngeal pathogenesis during an influenza virus co-infection

NIH-funded research University of Florida · NIH-10734055

This study is looking at how the flu virus can make bacterial infections, like those caused by Streptococcus pneumoniae, worse in the throat, and it aims to find ways to help people with the flu avoid serious complications like pneumonia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida NIH-funded
Lab location1 site (Gainesville, United States)
Project IDNIH-10734055 on NIH RePORTER

What this research studies

This research explores the role of the immune response, specifically IL-17, in the development of infections caused by Streptococcus pneumoniae when a person is also infected with the influenza virus. By using a model that mimics how these infections occur in humans, the researchers aim to understand how the flu virus can worsen bacterial infections in the nasopharynx, leading to serious diseases like pneumonia. The study involves examining the immune response and inflammation in the nasopharynx of infected mice to identify mechanisms that could be targeted for treatment. This research could provide insights into preventing severe bacterial infections in patients with influenza.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who are at risk of respiratory infections, particularly those with a history of influenza and bacterial infections.

Not a fit: Patients who do not have a history of respiratory infections or those who are not at risk for influenza-related complications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments or preventive strategies for patients suffering from respiratory infections during flu season.

How similar studies have performed: Previous research has shown that understanding the immune response in co-infections can lead to significant advancements in treatment strategies, indicating that this approach has potential for success.

Where this research is happening

Gainesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.